ReViral Ltd

ReViral Ltd

ReViral Ltd

ReViral is a UKbased biotechnology company developing firstinclass drugs to treat RSV infections.
Type
B2c
Founded
2011
Raised
$99M
Follow us
Alexa global traffic share
Twitter followers
01 Aug 2018
$55,000,000
Venture capital (Series B)

ReViral closes $55 million Series B funding round for RSV drug

MedCity News
+2